Burning Rock Biotech Limited Revenue Growth Rates (BNR), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Burning Rock Biotech Limited  (NASDAQ: BNR)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

BNR's Revenue Growth by Quarter and Year

Burning Rock Biotech Limited's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BNR Revenue (in millions $) FY 2025 FY 2024 FY 2023 FY 2022
4th Quarter December 77.16
3rd Quarter September 0.00
2nd Quarter June 0.00
1st Quarter March 0.00
FY 77.16

BNRs Annual Revenue
Burning Rock Biotech Limited's Revenue in the fiscal year 2025 $ 77.16 millions
Burning Rock Biotech Limited's Revenue in the fiscal year 2024 $ 70.67 millions
Burning Rock Biotech Limited's Revenue in the fiscal year 2023 $ 75.70 millions
Burning Rock Biotech Limited's Revenue in the fiscal year 2022 $ 81.66 millions
Burning Rock Biotech Limited's Revenue in the fiscal year 2021 $ 79.69 millions




BNR Revenue fourth quarter 2025 Y/Y Growth Comment
Burning Rock Biotech Limited achieved in the fourth quarter 2025, above Company average Revenue improvement of 9.18% year on year, to $ 77.16 millions.

Looking into fourth quarter 2025 results within Medical Laboratories industry 8 other companies have achieved higher Revenue growth. While Burning Rock Biotech Limited' s Revenue increase of 9.18% ranks overall at the positon no. 589 in the fourth quarter 2025.


BNR Revenue ( Y/Y Growth %) 2025
 2024 2023 2022
4th Quarter December 9.18 % -6.64 % -7.3 % 2.47 %
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY   9.18 % -6.64 % -7.3 % -

Financial Statements
Burning Rock Biotech Limited's fourth quarter 2025 Revenue $ 77.16 millions BNR's Income Statement
Burning Rock Biotech Limited's fourth quarter 2024 Revenue $ 70.67 millions Quarterly BNR's Income Statement


BNR Revenue (Quarter on Quarter Growth %)

 2025
 2024 2023 2022
4th Quarter December - - - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY (Year on Year)   9.18 % -6.64 % -7.3 % -


Back to BNR Growth rate Comparisons >> Back to BNR Growth rate Comparisons >>


Revenue fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #9
Healthcare Sector #140
Overall #589

Revenue Y/Y Growth Statistics
High Average Low
20.96 % 2.37 % -7.31 %
(Dec 31 2021)   (Dec 31 2023)
Revenue fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #9
Healthcare Sector #140
Overall #589
Revenue Y/Y Growth Statistics
High Average Low
20.96 % 2.37 % -7.31 %
(Dec 31 2021)   (Dec 31 2023)

Revenue by Quarter for the Fiscal Years 2022, 2023, 2024, 2025

Burning Rock Biotech Limited's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BNR's IV. Quarter Q/Q Revenue Comment


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BNR's IV. Quarter Q/Q Revenue Comment


Burning Rock Biotech Limited's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Dec 31 2024)		 12 Months Ending
(Dec 31 2023)		 12 Months Ending
(Dec 31 2022)		 12 Months Ending
(Dec 31 2021)
Cumulative Revenue 12 Months Ending $ 77.16 $ 70.67 $ 75.70 $ 81.66 $ 79.69
Y / Y Revenue Growth (TTM) 9.18 % -6.64 % -7.31 % 2.47 % 20.96 %
Year on Year Revenue Growth Overall Ranking # 3299 # 592 # 0 # 0 # 769
Seqeuential Revenue Change (TTM) 9.18 % -6.64 % -7.31 % 2.47 % 20.96 %
Seq. Revenue Growth (TTM) Overall Ranking # 3332 # 592 # 0 # 0 # 769


Cumulative Revenue growth Comment
Burning Rock Biotech Limited saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 9.18% year on year, to $ 77 millions if the fiscal year would have ended in Dec 31 2025.
Burning Rock Biotech Limited's trailing twelve months Revenue growth was higher than company's average 3.73% and higher than -6.64% growth in Dec 31 2024.

In the Healthcare sector 441 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 592 to 3299.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 33
Healthcare Sector # 442
Overall # 3299

Revenue TTM Y/Y Growth Statistics
High Average Low
20.96 %
 3.73 %
-7.31 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 33
Sector # 443
S&P 500 # 3332
Cumulative Revenue growth Comment
Burning Rock Biotech Limited saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 9.18% year on year, to $ 77 millions if the fiscal year would have ended in Dec 31 2025.
Burning Rock Biotech Limited's trailing twelve months Revenue growth was higher than company's average 3.73% and higher than -6.64% growth in Dec 31 2024.
The momentum is even more impressive from twelve months ended Dec 31 2024 exhibited at 9.18 % increase from $70.67 millions in the period from Dec 31 2024 to Dec 31 2021.

In the Healthcare sector 441 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 592 to 3299.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 33
Healthcare Sector # 442
Overall # 3299

Revenue TTM Y/Y Growth Statistics
High Average Low
20.96 %
3.73 %
-7.31 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 33
Sector # 443
S&P 500 # 3332




Other Revenue Growth
Medical Laboratories Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
BNR's Revenue Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue increase for the quarter ending Dec 31 2025 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2025
Orthopediatrics Corp15.95%$ 15.945 millions
Concentra Group Holdings Parent Inc 15.92%$ 15.921 millions
Boston Scientific Corporation15.90%$ 15.896 millions
Electromed Inc 15.77%$ 15.774 millions
Evolus Inc 15.64%$ 15.636 millions
Lemaitre Vascular Inc 15.20%$ 15.197 millions
Envista Holdings Corporation15.01%$ 15.011 millions
Radnet Inc 14.80%$ 14.800 millions
Innovage Holding Corp 14.69%$ 14.693 millions
Kamada Ltd 14.54%$ 14.544 millions
Idexx Laboratories Inc14.40%$ 14.398 millions
Cerus Corporation14.33%$ 14.331 millions
Grail Inc 13.97%$ 13.973 millions
Dr Reddy s Laboratories Limited13.76%$ 13.761 millions
Pacific Biosciences Of California Inc 13.75%$ 13.750 millions
Dexcom Inc 13.19%$ 13.189 millions
Atricure Inc 13.05%$ 13.054 millions
Collegium Pharmaceutical Inc 12.92%$ 12.916 millions
Inspire Medical Systems inc 12.58%$ 12.577 millions
Qhslab Inc 12.43%$ 12.433 millions
Pacs Group Inc 12.43%$ 12.426 millions
U S Physical Therapy Inc12.35%$ 12.347 millions
Elanco Animal Health Incorporated12.16%$ 12.157 millions
Livanova Plc11.62%$ 11.618 millions
Amneal Pharmaceuticals Inc 11.59%$ 11.591 millions
Karyopharm Therapeutics Inc 11.58%$ 11.581 millions
Escalon Medical Corp 11.51%$ 11.515 millions
Stryker Corp11.42%$ 11.420 millions
Warby Parker Inc 11.41%$ 11.409 millions
Sight Sciences Inc 11.38%$ 11.385 millions


About Burning Rock Biotech Limited Revenue Growth Rates (BNR), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Burning Rock Biotech Ltd (CIK 1792267).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001193125-26-183377
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Burning Rock Biotech Ltd’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.